<DOC>
	<DOCNO>NCT01469910</DOCNO>
	<brief_summary>The purpose study assess safety pharmacokinetics single ascend dos Simotinib Hydrochloride healthy subject .</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics Single Ascending Doses Simotinib Hydrochloride Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy , male female subject Age 18 45 year Body Mass Index ( BMI ) 19 24 kg/m2 ; total body weight &gt; 50 kg male , &gt; 45 kg female Written inform consent sign date subject Subjects willing able comply study procedures Any clinically significant disease surgery within 4 week prior begin study Known hypersensitivity study drug similar drug History serious disease , include limited circulatory system , endocrine system , central nervous system , hematology , immunology , metabolic disease psychiatric disorder History gastrointestinal , hepatic , renal disease , affect drug absorption metabolism Any clinically significant abnormal clinical laboratory test Abnormal ECG vital sign A positive test HIV antibody A positive prestudy Hepatitis B surface antigen positive Hepatitis C antibody result History alcohol consumption within six month study define : average weekly intake &gt; 14 unit History regular tobacco use nicotine containing product within three month prior screen Consumption much tea coffee ( &gt; 8 cups/day ) Use drug , inhibits induces hepatic drug metabolism , within 30 day prior begin study Use drug within 14 day prior begin study Participate clinical trial within 30 day prior begin study Blood donation within 30 day dose All female subject must childbearing potential Pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>